NEWS NAVIGATOR
Englemed logo
SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
ENGLEMED
Contact Englemed
Send an e-mail with your comments!
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
TODAY'S NEWS
Sleep disease link to cancer
Mon May 21st - There may be a link between sleep disorder and cancer, researchers have reported. More
Glow hope for medicine
Mon May 21st - Scientists have taken a further step towards bringing tiny glowing crystals, known as quantum dots, into medicine, it has been revealed. More
Heart drugs may prevent cancer
Mon May 21st - Statins were developed to reduce cholesterol and found to have a range of other benefits for heart patients - and new findings suggest this may include preventing cancer. More
RECENT COMMENTS
On 21/05/2012 Editor wrote:
Useful link from the ESC for people concerned abou - Read more

On 11/05/2012 Anonymous wrote:
In fact the biggest risk is the patch and the ring - Read more

On 10/05/2012 Editor wrote:
Welcome to Englemed comments. We'd like your view - Read more

THIS WEEK'S STORIES
Day-time abstention may help combat obesity
Fri May 18th - Regular eating times and fasting for a number of hours a day might prove to be beneficial to our health, a US study has claimed. More
Conflict over diet advice for pregnant women
Fri May 18th - Pregnant women can reduce the risk of developing serious complications by following a calorie controlled diet, researchers say today. More
Athlete pain tolerance could aid treatment
Fri May 18th - Athletes’ ability to tolerate pain for longer than non-athletes could give pain management specialists new ways of treating patients, researchers reported yesterday. More
New heart medicine drive
Thurs May 17th - People with high cholesterol are being encouraged to take their medicines today as research highlighted the benefits of the medicines. More
Nine new breast cancer genes
Thurs May 17th - Nine new genes have been found linked to breast cancer, British scientists revealed last night. More
ENGLEMED HEALTH NEWS

Seed that could aid quitters

Thursday September 29th, 2011

A nicotine substitute found in laburnum seeds could play a significant role in helping smokers' to quit, it was revealed last night.

British and Polish researchers conducted what may be the first placebo-controlled trial of cytisine pills.

Campaigners were celebrating the success of the trial, which suggested the substance could help wean smokers off nicotine addiction.

The research, reported in the New England Journal of Medicine, involved some 740 smokers, who took cytisine or a dummy drug for 25 days. Researchers kept counselling support to a minimum.

After a year about 8.4 per cent of the cytisine users were non-smokers - compared with 2.4 per cent of those given fake pills.

The research was conducted in Warsaw, Poland, at University College London, UK, and at Birmingham University, UK.

Cytisine, marketed as Tabex, is poisonous in large doses but has been used in parts of eastern Europe for 40 years.

Doireann Maddock, of the British Heart Foundation, said: "We need some bigger trials first but this pill may yet offer a low cost treatment to help people break this harmful habit.

“In the meantime, those looking to quit smoking should speak to their GP about the huge range of proven services that are out there to help.”

She added: "If you want to live a longer and healthier life, stopping smoking is the single most important thing you can do. However, even though it is a major risk factor for heart disease, it can be a challenging habit to break."

Placebo-Controlled Trial of Cytisine for Smoking Cessation. Robert West et al, New England Journal of Medicine, September 2011.365;13

Tags: Drug and Alcohol Abuse | Europe | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

CATEGORIES